Verastem Inc (VSTM)
10.90
+0.54
(+5.21%)
USD |
NASDAQ |
May 03, 16:00
10.57
-0.33
(-3.03%)
After-Hours: 20:00
Verastem Free Cash Flow: -86.46M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -86.46M |
| September 30, 2023 | -73.40M |
| June 30, 2023 | -71.89M |
| March 31, 2023 | -64.68M |
| December 31, 2022 | -63.67M |
| September 30, 2022 | -56.99M |
| June 30, 2022 | -52.74M |
| March 31, 2022 | -53.46M |
| December 31, 2021 | -53.70M |
| September 30, 2021 | -65.47M |
| June 30, 2021 | -9.90M |
| March 31, 2021 | -19.05M |
| December 31, 2020 | -33.54M |
| September 30, 2020 | -49.06M |
| June 30, 2020 | -121.65M |
| March 31, 2020 | -133.75M |
| December 31, 2019 | -138.52M |
| September 30, 2019 | -142.76M |
| June 30, 2019 | -138.03M |
| March 31, 2019 | -114.25M |
| December 31, 2018 | -98.02M |
| September 30, 2018 | -76.90M |
| June 30, 2018 | -65.62M |
| March 31, 2018 | -69.21M |
| December 31, 2017 | -57.31M |
| Date | Value |
|---|---|
| September 30, 2017 | -42.94M |
| June 30, 2017 | -37.14M |
| March 31, 2017 | -29.35M |
| December 31, 2016 | -29.52M |
| September 30, 2016 | -33.78M |
| June 30, 2016 | -39.34M |
| March 31, 2016 | -44.67M |
| December 31, 2015 | -45.77M |
| September 30, 2015 | -45.78M |
| June 30, 2015 | -44.87M |
| March 31, 2015 | -41.97M |
| December 31, 2014 | -39.33M |
| September 30, 2014 | -35.67M |
| June 30, 2014 | -32.08M |
| March 31, 2014 | -29.31M |
| December 31, 2013 | -26.36M |
| September 30, 2013 | -25.71M |
| June 30, 2013 | -25.49M |
| March 31, 2013 | -24.22M |
| December 31, 2012 | -22.91M |
| September 30, 2012 | -21.10M |
| June 30, 2012 | -18.85M |
| March 31, 2012 | -14.32M |
| December 31, 2011 | -9.372M |
Free Cash Flow Range, Past 5 Years
-142.76M
Minimum
Sep 2019
-9.90M
Maximum
Jun 2021
-75.19M
Average
-64.68M
Median
Mar 2023
Free Cash Flow Benchmarks
| Johnson & Johnson | 18.23B |
| Geron Corp | -184.70M |
| Altimmune Inc | -75.86M |
| Oragenics Inc | -7.291M |
| Actinium Pharmaceuticals Inc | -39.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.68M |
| Cash from Investing (Quarterly) | 12.44M |
| Cash from Financing (Quarterly) | -0.446M |
| Free Cash Flow Per Share (Quarterly) | -1.105 |
| Free Cash Flow Yield | -36.01% |